WHEAT GERM FOR THE TREATMENT OF PARASITES

Not Applicable

• Conditions: -B829 Intestinal parasitism, unspecified; Intestinal parasitism, unspecified; B829

• Registration Number: PER-031-01
• Lead Sponsor: INSTITUTO DE INVESTIGACION NUTRICIONAL,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2001-06-22
• Last Update Posted: 4 September 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

• Giardia lamblia confirmed by ELISA.
• Age greater than twelve months and less than or equal to 5 years (exceptionally older children).
• Plan to reside in Lima for more than 2 months.
• Symptomatic: Gastrointestinal symptom: diarrhea, abdominal pain, cramps. Abdominal distention, vomiting
• Asymptomatic: No gastrointestinal symptoms

Exclusion Criteria

Symptomatic:
• Dysentery (nalidixic acid will be indicated)
• Severe diarrhea requiring hospitalization.
• Significant medical condition (pneumonia, cancer, etc.)
• Immuno suppressive therapy (eg steroids greater than or equal to 2mg / kg / d).
• While you are taking an antibiotic for some reason.
• Prior enrollment.
• Wheat allergy.
Asymptomatic:
• Diarrhea.
• Bloating or abdominal pain, vomiting.
• Other gastrointestinal symptoms.
• The other criteria of the symptomatic patient are repeated

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br>Outcome name:Clinical evolution: based on the selection of data that will be evaluated according to the pre-established group, Stool test by ELISA test for giardia<br>Measure:Frequency of parasitosis<br>Timepoints:Durinf and after treatment<br>

Secondary Outcome Measures

Name	Time	Method
<br>Outcome name:Stool test by ELISA test for giardia, microscope and coproculture according to the group. Blood test: hemoglobin.<br>Measure:Laboratory Exams<br>Timepoints:During and after treatment<br>;<br>Outcome name:Age and education of parents, type of house (walls, floor) and basic services, number of people in the house, siblings.<br>Measure:Sociodemographic information<br>Timepoints:Before treatment<br>;<br>Outcome name:Based on the selection of data that will be evaluated according to the pre-established group<br>Measure:Clinical evolution<br>Timepoints:During treatment<br>